• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy.

作者信息

Katz A E, de Vries G M, Benson M C, Buttyan R E, O'Toole K, Rubin M A, Stifelman M, Olsson C A

机构信息

Department of Urology, Columbia University, New York, New York, USA.

出版信息

Urol Clin North Am. 1996 Nov;23(4):541-9. doi: 10.1016/s0094-0143(05)70334-7.

DOI:10.1016/s0094-0143(05)70334-7
PMID:8948409
Abstract

Prostate cells present in the peripheral circulation can be detected using an enhanced reverse-transcriptase polymerase chain reaction (RT-PCR) for prostate-specific antigen (PSA) assay. In one study, preoperative enhanced RT-PCR for PSA status was a significant predictor of surgical pathology and postoperative biomechanical recurrence. The use of RT-PCR may enhance the urologist's ability to stage potential candidates for radical prostatectomy, as the assay is a more sensitive and specific predictor of microscopic extracapsular extension than conventional staging modalities. This highly adaptable assay also may have roles in screening for recurrence and in staging other solid tumors.

摘要

相似文献

1
The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy.
Urol Clin North Am. 1996 Nov;23(4):541-9. doi: 10.1016/s0094-0143(05)70334-7.
2
Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.术前前列腺特异性抗原的逆转录聚合酶链反应可预测根治性前列腺切除术后的治疗失败。
J Urol. 1996 May;155(5):1557-62.
3
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.前列腺癌根治术后患者早期外周血前列腺特异性抗原逆转录聚合酶链反应检测与前列腺癌进展相关。
Cancer Res. 2003 Sep 15;63(18):5874-8.
4
Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.前列腺癌的分子分期。II. 用于前列腺特异性抗原与前列腺特异性膜抗原的增强逆转录酶聚合酶链反应检测方法应用的比较。
J Urol. 1995 May;153(5):1373-8.
5
The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer.使用逆转录聚合酶链反应进行前列腺特异性抗原检测以预测根治性前列腺切除术之前的潜在手术失败:前列腺癌的分子分期
Br J Urol. 1996 Mar;77(3):411-7. doi: 10.1046/j.1464-410x.1996.90616.x.
6
Can the reverse transcriptase-polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence?用于检测前列腺特异性抗原和前列腺特异性膜抗原的逆转录聚合酶链反应能否改善分期并预测生化复发?
BJU Int. 2002 Oct;90(6):579-85. doi: 10.1046/j.1464-410x.2002.02972.x.
7
Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.术前对前列腺特异性抗原和前列腺特异性膜抗原进行联合巢式逆转录聚合酶链反应,与接受根治性前列腺切除术的局限性前列腺癌患者的病理分期或生化复发无关。
J Clin Oncol. 2002 Aug 1;20(15):3213-8. doi: 10.1200/JCO.2002.11.097.
8
Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy.用于前列腺特异性抗原检测的基于血液的逆转录聚合酶链反应分析:长期随访证实了该检测方法在识别前列腺癌根治术后更有可能出现生化复发(前列腺特异性抗原升高)患者方面的潜在效用。
Int J Cancer. 1999 Aug 20;84(4):360-4. doi: 10.1002/(sici)1097-0215(19990820)84:4<360::aid-ijc5>3.0.co;2-e.
9
Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases.采用逆转录聚合酶链反应(RT-PCR)检测外周血和淋巴结中前列腺特异性抗原对前列腺癌进行分子分期:与标准组织学分期及隐匿性区域淋巴结转移的免疫组化评估相比较
Eur Urol. 2003 Apr;43(4):342-50. doi: 10.1016/s0302-2838(03)00055-1.
10
Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomy.前列腺癌根治术后盆腔手术切缘分子分期中前列腺特异性抗原的逆转录聚合酶链反应
Urology. 2001 May;57(5):1006-11. doi: 10.1016/s0090-4295(00)01123-7.

引用本文的文献

1
Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.前列腺癌患者循环肿瘤细胞的检测:方法学陷阱与临床相关性
Mol Med. 2009 Mar-Apr;15(3-4):101-14. doi: 10.2119/molmed.2008.00116. Epub 2008 Dec 3.
2
Peripheral blood rt-PCR assays for detection and prognosis of prostate cancer.用于前列腺癌检测和预后评估的外周血逆转录聚合酶链反应检测
Rev Urol. 2003 Winter;5(1):54-8.
3
Molecular staging by RT-pCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer.
通过逆转录聚合酶链反应(RT-pCR)分析外周血和骨髓样本中的前列腺特异性抗原(PSA)和前列腺特异性膜抗原(PSMA)进行分子分期,是临床局限性前列腺癌根治性前列腺切除术后生化复发时间的独立预测指标。
Clin Exp Metastasis. 2004;21(6):495-505. doi: 10.1007/s10585-004-3217-0.
4
Clinical usefulness of RT-PCR detection of hematogenous prostate cancer spread.逆转录聚合酶链反应检测血行性前列腺癌转移的临床应用价值
Urol Res. 1997;25(6):373-84. doi: 10.1007/BF01268851.